TearLab Corporation and PRN Physician Recommended Nutriceuticals recently announced they have entered into a definitive co-promotion agreement through which TearLab and PRN will jointly promote PRN's patented omega-3 formulations, including Dry Eye Omega Benefits®.
According to the companies, PRN’s marketed omega-3 formulations have been shown to reduce osmolarity levels in dry eye patients utilizing the TearLab Osmolarity System, which provides an objective assessment to diagnose and manage patients with dry eye disease (DED).
TearLab currently markets the TearLab Osmolarity System and has over 4,000 devices placed in the U.S., while PRN currently markets several patented omega-3 brands including Dry Eye Omega Benefits® and Dry Eye Omega Benefits® Liquid.
Click here to read the full press release.
Source: TearLab Corporation